Jalra M (500+50) Tablet | Price, Usage, Dosage, Composition, and Brand Substitutes - Fixed-Dose Combination (FDC) Drug
Jalra M (500+50) Tablet
Jalra M (500+50) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by US Vitamins Limited. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Metformin, Vidagliptin. This drug comes in the form of Tablet. The general packing available for this medicine consists of 10 Tablet and is priced at Rs 220 (arround $3.08 US Dollar)| Generic (Salt) Combination : | (Metformin+ Vidagliptin) |
| Pharma Company : | US Vitamins Limited |
| Brand Label : | Jalra M (500+50) |
| Preparation Type : | Tablet |
| Single Dose : | 1 Tablet |
| Composition (Fixed-Dose Combination) : |
|
| Pack Size/Qty/Vol : | 10 Tablet |
| Price Unit : | Rs 22 INR (arround $0.308 US Dollar) |
| Price Pack : | Rs 220 INR (arround $3.08 US Dollar) |
Drug details for Jalra M (500+50)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Jalra M (500+50) are :
Metformin
Indication (Prescribed for or used as): Metformin is used alone or with other medications, including insulin, to treat type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in the blood). Metformin is in a class of drugs called biguanides. Metformin helps to control the amount of glucose (sugar) in your blood. It decreases the amount of glucose you absorb from your food and the amount of glucose made by your liver. Metformin also increases your body's response to insulin, a natural substance that controls the amount of glucose in the blood. Metformin is not used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood).Over time, people who have diabetes and high blood sugar can develop serious or life-threatening complications, including heart disease, stroke, kidney problems, nerve damage, and eye problems. Taking medication(s), making lifestyle changes (e.g., diet, exercise, quitting smoking), and regularly checking your blood sugar may help to manage your diabetes and improve your health. This therapy may also decrease your chances of having a heart attack, stroke, or other diabetes-related complications such as kidney failure, nerve damage (numb, cold legs or feet; decreased sexual ability in men and women), eye problems, including changes or loss of vision, or gum disease. Your doctor and other healthcare providers will talk to you about the best way to manage your diabetes.
For more details on Metformin, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Metformin..
VidagliptinIndication (Prescribed for or used as): Type II Diabetes Mellitus.
For more details on Vidagliptin, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Vidagliptin..
Jalra M (500+50) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 2 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Jalra M (500+50), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Metformin-500 mg Vidagliptin-50 mg).Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.
| Brand | Price (Rs.) | Brand | Price (Rs.) |
| Galvus MET (50+500) | 214 | Zomelis MET (50+500) | 215 |